Crystal structure of ({(E)-[3-(1H-imidazol-1-yl)-1-phenylpropylidene]amino}- oxy)(4-methylphenyl)methanone, C20H19N3O2

被引：1

作者：

Almutairi, Maha S. ^{[1
]}

Attia, Mohamed I. ^{[1
,2
]}

Ghabbour, Hazem A. ^{[1
]}

Ghoneim, Soraya W. ^{[1
]}

Abdel-Aziz, Hatem A. ^{[1
]}

Fun, Hoong-Kun ^{[1
,3
]}

机构：

[1] King Saud Univ, Dept Pharmaceut Chem, Coll Pharm, Riyadh 11451, Saudi Arabia

[2] Natl Res Ctr, Pharmaceut & Drug Ind Res Div, Med & Pharmaceut Chem Dept, Giza 12622, Egypt

[3] Univ Sains Malaysia, Sch Phys, Xray Crystallog Unit, George Town 11800, Malaysia

来源：

ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES | 2014年 / 229卷 / 04期

关键词：

D O I：

10.1515/ncrs-2014-0155

中图分类号：

O7 [晶体学];

学科分类号：

0702 ; 070205 ; 0703 ; 080501 ;

摘要：

C20H19N3O2, monoclinic, P2 (1)/c (no. 14), a = 16.3620(2) angstrom b = 8.1179(2) angstrom. c = 14.4252(2) angstrom, beta = 113.861(1)degrees, V = 1752.3 angstrom(3), Z = 4, R-gt(F) = 0.0385, wR(ref)(F-2) = 0.1200, T = 293 K.

引用

页码：307 / 308

页数：2

共 50 条

[1] Structural Properties and Biological Prediction of ({[(1E)-3-(1H-Imidazol-1-yl)-1-phenylpropylidene]amino}oxy)(4-methylphenyl)methanone: An In Silico Approach
Almutairi, Maha S.
Manimaran, Devarasu
Joe, Issac Hubert
Saleh, Ola A.
Attia, Mohamed I.
SYMMETRY-BASEL, 2016, 8 (01):
[2] Crystal structure of (4-chlorophenyl)({(E)-[3-(1H-imidazol-1-yl)-1-phenylpropylidene]amino}oxy)methanone, C18H16ClN3O2
Attia, Mohamed I.
Ghabbour, Hazem A.
Almutairi, Maha S.
Ghoneim, Soraya W.
Fun, Hoong-Kun
ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2014, 229 (01): : 45 - 46
[3] 1-{(E)-[3-(1H-Imidazol-1-yl)-1-phenylpropylidene]amino}-3-(2-methylphenyl)urea
Attia, Mohamed I.
Aboul-Enein, Mohamed N.
El-Brollosy, Nasser R.
Ng, Seik Weng
Tiekink, Edward R. T.
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O1848 - +
[4] Crystal structure of (2E)-2-[3-(1H-imidazol-1-yl)-1-phenylpropylidene]- N-(4-methylphenyl)hydrazinecarboxamide, C20H21N5O
Attia, Mohamed I.
Ghabbour, Hazem A.
Darwish, Hany W.
Fun, Hoong-Kun
ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2014, 229 (04): : 311 - 312
[5] In vitro anti-Candida activity and single crystal X-ray structure of ({(1E)-[3-(1H-imidazol-1-yl)-1-phenylpropylidene]amino}oxy)(4-nitrophenyl)methanone
Attia, Mohamed I.
Ghabbour, Hazem A.
Zakaria, Azza S.
Fun, Hoong-Kun
BANGLADESH JOURNAL OF PHARMACOLOGY, 2014, 9 (01) : 43 - 48
[6] Crystal structure of (2E)-2-[3-(1H-imidazol-1-yl)-1-phenylpropylidene]-hydrazinecarboxamide monohydrate, C13H17N5O2
Attia, Mohamed I.
Ghabbour, Hazem A.
Fun, Hoong-Kun
ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2015, 230 (03): : 249 - 250
[7] X-ray Molecular Structure of ({[(1E)-3-(1H-Imidazol-1-yl)-1-phenylpropylidene]amino}oxy)(3,4,5-trimethoxyphenyl)-methanone: A Potential Anti-Candida Agent
Almutairi, Maha S.
Ghabbour, Hazem A.
Ghoneim, Soraya W.
Fun, Hoong-Kun
Attia, Mohamed I.
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2015, 14 (11) : 2041 - 2046
[8] Spectroscopic Investigations, DFT Calculations, and Molecular Docking Studies of the Anticonvulsant (2E)-2-[3-(1H-Imidazol-1-yl)-1-phenylpropylidene]-N-(4-methylphenyl)hydrazinecarboxamide
Al-Wabli, Reem I.
Manimaran, Devarasu
John, Liji
Joe, Isaac Hubert
Haress, Nadia G.
Attia, Mohamed I.
JOURNAL OF SPECTROSCOPY, 2016, 2016
[9] Synthesis and Single Crystal X-Ray Structure of New (2E)-2-[3-(1H-Imidazol-1-yl)-1-phenylpropylidene]-N-phenylhydrazinecarboxamide
Attia, Mohamed I.
Ghabbour, Hazem A.
El-Azzouny, Aida A.
Al-Deeb, Omar A.
Almutairi, Maha S.
Fun, Hoong-Kun
JOURNAL OF CHEMISTRY, 2013, 2013
[10] (E)-N-[3-(Imidazol-1-yl)-1-phenylpropylidene]hydroxylamine
Fun, Hoong-Kun
Quah, Ching Kheng
Attia, Mohamed I.
Almutairi, Maha S.
Ghoneim, Soraya W.
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O627 - U1560

← 1 2 3 4 5 →